545 related articles for article (PubMed ID: 24615622)
1. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
[TBL] [Abstract][Full Text] [Related]
2. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice.
Fermoselle C; García-Arumí E; Puig-Vilanova E; Andreu AL; Urtreger AJ; de Kier Joffé ED; Tejedor A; Puente-Maestu L; Barreiro E
Exp Physiol; 2013 Sep; 98(9):1349-65. PubMed ID: 23625954
[TBL] [Abstract][Full Text] [Related]
4. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Approaches in Mitochondrial Dysfunction, Proteolysis, and Structural Alterations of Diaphragm and Gastrocnemius in Rats With Chronic Heart Failure.
Barreiro E; Puig-Vilanova E; Marin-Corral J; Chacón-Cabrera A; Salazar-Degracia A; Mateu X; Puente-Maestu L; García-Arumí E; Andreu AL; Molina L
J Cell Physiol; 2016 Jul; 231(7):1495-513. PubMed ID: 26530247
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer.
Puig-Vilanova E; Rodriguez DA; Lloreta J; Ausin P; Pascual-Guardia S; Broquetas J; Roca J; Gea J; Barreiro E
Free Radic Biol Med; 2015 Feb; 79():91-108. PubMed ID: 25464271
[TBL] [Abstract][Full Text] [Related]
7. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
8. Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia.
Op den Kamp CM; Langen RC; Snepvangers FJ; de Theije CC; Schellekens JM; Laugs F; Dingemans AM; Schols AM
Am J Clin Nutr; 2013 Sep; 98(3):738-48. PubMed ID: 23902785
[TBL] [Abstract][Full Text] [Related]
9. The phosphodiesterase-4 inhibitor roflumilast reverts proteolysis in skeletal muscle cells of patients with COPD cachexia.
Barreiro E; Puig-Vilanova E; Salazar-Degracia A; Pascual-Guardia S; Casadevall C; Gea J
J Appl Physiol (1985); 2018 Aug; 125(2):287-303. PubMed ID: 29648516
[TBL] [Abstract][Full Text] [Related]
10. Reduced lung cancer burden by selective immunomodulators elicits improvements in muscle proteolysis and strength in cachectic mice.
Salazar-Degracia A; Granado-Martínez P; Millán-Sánchez A; Tang J; Pons-Carreto A; Barreiro E
J Cell Physiol; 2019 Aug; 234(10):18041-18052. PubMed ID: 30851071
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and metabolic features of mouse diaphragm and gastrocnemius muscles in chronic lung carcinogenesis: influence of underlying emphysema.
Salazar-Degracia A; Blanco D; Vilà-Ubach M; de Biurrun G; de Solórzano CO; Montuenga LM; Barreiro E
J Transl Med; 2016 Aug; 14(1):244. PubMed ID: 27549759
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Approaches in an Experimental Model of Non-Small Cell Lung Cancer: Effects on Tumor Biology.
Mateu-Jimenez M; Fermoselle C; Rojo F; Mateu J; Peña R; Urtreger AJ; Diament MJ; Joffé ED; Pijuan L; Herreros AG; Barreiro E
Curr Pharm Des; 2016; 22(34):5300-5310. PubMed ID: 27339432
[TBL] [Abstract][Full Text] [Related]
14. Curcumin and Resveratrol Improve Muscle Function and Structure through Attenuation of Proteolytic Markers in Experimental Cancer-Induced Cachexia.
Penedo-Vázquez A; Duran X; Mateu J; López-Postigo A; Barreiro E
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443492
[TBL] [Abstract][Full Text] [Related]
15. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
16. Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.
Psallidas I; Karabela SP; Moschos C; Sherrill TP; Kollintza A; Magkouta S; Theodoropoulou P; Roussos C; Blackwell TS; Kalomenidis I; Stathopoulos GT
Mol Cancer; 2010 Mar; 9():56. PubMed ID: 20219102
[TBL] [Abstract][Full Text] [Related]
17. MG132-mediated inhibition of the ubiquitin-proteasome pathway ameliorates cancer cachexia.
Zhang L; Tang H; Kou Y; Li R; Zheng Y; Wang Q; Zhou X; Jin L
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1105-15. PubMed ID: 23535871
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1(-/-) and Parp-2(-/-) mice with lung cancer cachexia.
Chacon-Cabrera A; Fermoselle C; Salmela I; Yelamos J; Barreiro E
Biochim Biophys Acta; 2015 Dec; 1850(12):2530-43. PubMed ID: 26432600
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice.
Tsubouchi H; Yanagi S; Miura A; Matsumoto N; Kangawa K; Nakazato M
Eur J Pharmacol; 2014 Nov; 743():1-10. PubMed ID: 25257464
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
Tilignac T; Temparis S; Combaret L; Taillandier D; Pouch MN; Cervek M; Cardenas DM; Le Bricon T; Debiton E; Samuels SE; Madelmont JC; Attaix D
Cancer Res; 2002 May; 62(10):2771-7. PubMed ID: 12019153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
